Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1

Patients with atrial fibrillation (AF) have a high risk of stroke and mortality, which can be considerably reduced by oral anticoagulants (OAC). Recently, four non-vitamin-K oral anticoagulants (NOACs) were compared with warfarin in large randomized trials for the prevention of stroke and systemic e...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Eur Heart J
Главные авторы: Diener, Hans-Christoph, Aisenberg, James, Ansell, Jack, Atar, Dan, Breithardt, Günter, Eikelboom, John, Ezekowitz, Michael D., Granger, Christopher B., Halperin, Jonathan L., Hohnloser, Stefan H., Hylek, Elaine M., Kirchhof, Paulus, Lane, Deirdre A., Verheugt, Freek W.A., Veltkamp, Roland, Lip, Gregory Y.H.
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Reviews
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837588/
https://ncbi.nlm.nih.gov/pubmed/26848149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehv643
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы